National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, China.
Department of Clinical Pathology, Faculty of Veterinary Medicine, Benha University, Benha, Egypt.
Drug Deliv. 2020 Dec;27(1):292-308. doi: 10.1080/10717544.2020.1724209.
is one of the most important zoonotic bacterial pathogens, infecting human beings and a wide range of animals, in particular, dairy cattle. Globally. causing bovine mastitis is one of the biggest problems and an economic burden facing the dairy industry with a strong negative impact on animal welfare, productivity, and food safety. Furthermore, its smart pathogenesis, including facultative intracellular parasitism, increasingly serious antimicrobial resistance, and biofilm formation, make it challenging to be treated by conventional therapy. Therefore, the development of nanoparticles, especially liposomes, polymeric nanoparticles, solid lipid nanoparticles, nanogels, and inorganic nanoparticles, are gaining traction and excellent tools for overcoming the therapeutic difficulty accompanied by mastitis. Therefore, in this review, the current progress and challenges of nanoparticles in enhancing the mastitis therapy are focused stepwise. Firstly, the treatment difficulties by the antimicrobial drugs are analyzed. Secondly, the advantages of nanoparticles in the treatment of mastitis, including improving the penetration and accumulation of their payload drugs intracellular, decreasing the antimicrobial resistance, and preventing the biofilm formation, are also summarized. Thirdly, the progression of different types from the nanoparticles for controlling the mastitis are provided. Finally, the difficulties that need to be solved, and future prospects of nanoparticles for mastitis treatment are highlighted. This review will provide the readers with enough information about the challenges of the nanosystem to help them to design and fabricate more efficient nanoformulations against infections.
是最重要的人畜共患细菌性病原体之一,感染人类和广泛的动物,特别是奶牛。在全球范围内,引起奶牛乳腺炎是乳制品行业面临的最大问题和经济负担之一,对动物福利、生产力和食品安全产生强烈的负面影响。此外,其智能发病机制,包括兼性细胞内寄生、日益严重的抗微生物药物耐药性和生物膜形成,使得常规治疗变得具有挑战性。因此,纳米颗粒的发展,特别是脂质体、聚合物纳米颗粒、固体脂质纳米颗粒、纳米凝胶和无机纳米颗粒,正受到关注,是克服乳腺炎伴随的治疗困难的优秀工具。因此,在这篇综述中,逐步集中讨论了纳米颗粒在增强乳腺炎治疗方面的最新进展和挑战。首先,分析了抗菌药物治疗的困难。其次,总结了纳米颗粒在治疗乳腺炎方面的优势,包括提高细胞内其有效载荷药物的穿透和积累、降低抗菌药物耐药性和防止生物膜形成。第三,提供了不同类型的纳米颗粒控制乳腺炎的进展。最后,强调了纳米颗粒治疗乳腺炎需要解决的困难和未来展望。这篇综述将为读者提供有关纳米系统挑战的足够信息,帮助他们设计和制造更有效的纳米制剂来对抗感染。